Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

2.58
Delayed Data
As of 3:59pm ET
 -0.06 / -2.27%
Today’s Change
1.40
Today|||52-Week Range
13.80
-48.81%
Year-to-Date
Institutional investors control 8.74% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2016, these large investors purchased a net $14.5 thousand shares.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

5/23/2017MORGAN STANLEY & CO. LLC  Bought 68.3 Thousand shares of Rosetta Genomics Ltd
6/30/2017CREATIVE PLANNING, INC.  Sold 117.00 shares of Rosetta Genomics Ltd

Top 10 Owners of Rosetta Genomics Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Morgan Stanley & Co. LLC5.49%130,538306,764+68,299+109.74%
Highlander Capital Management LLC1.38%32,92377,369-534-1.60%
Empery Asset Management LP1.35%32,17875,618-53,759-62.56%
KCG Americas LLC0.48%11,42526,849+6,127+115.65%
SEI Investments Management Corp.0.01%270635-1-0.37%
Wells Fargo Advisors Financial Ne...0.01%16739200.00%
UBS Financial Services, Inc.0.01%12529400.00%
Citigroup Global Markets, Inc. (I...0.00%84197+1+1.20%
Morgan Stanley Smith Barney LLC (...0.00%64150-9-12.33%
FSC Securities Corp.0.00%57134+57--

Top 10 Mutual Funds Holding Rosetta Genomics Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change